0001104659-24-100976.txt : 20240918 0001104659-24-100976.hdr.sgml : 20240918 20240918161505 ACCESSION NUMBER: 0001104659-24-100976 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240916 FILED AS OF DATE: 20240918 DATE AS OF CHANGE: 20240918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORDON MICHAEL S CENTRAL INDEX KEY: 0001034608 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41429 FILM NUMBER: 241307653 MAIL ADDRESS: STREET 1: C/O VINIK ASSET MANAGEMENT LP STREET 2: 260 FRANKLIN STREET, SUITE 1900 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 4 1 tm2424268-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-09-16 0 0001374339 ProMIS Neurosciences Inc. PMN 0001034608 GORDON MICHAEL S C/O TROVE, 40 BROAD STREET BOSTON MA 02109 0 0 1 0 0 Common Shares, no par value 2024-09-16 4 P 0 76931 1.2228 A 76931 D Common Shares, no par value 2024-09-17 4 P 0 16292 1.40 A 93223 D Common Shares, no par value 2075629 I By Title 19 Promis Common Shares, no par value 48333 I By Title 19 Acies The price reported in Column 4 is a weighted average price. These shares were purchased in forty-two separate transactions, with prices ranging from $1.1200 to $1.3700 for an average weighted purchase price of $1.2228 rounded to the nearest ten thousandth. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased in each transaction. The price reported in Column 4 is a weighted average price. These shares were purchased in four separate transactions, with prices ranging from $1.37 to $1.40 for an average weighted purchase price of $1.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased in each transaction. By Title 19 Promis, a series of a Delaware limited liability company, of which the Reporting Person is the sole manager. By Title 19 Acies, a series of a Delaware limited liability company, of which the Reporting Person is the sole manager. /s/ Michael S. Gordon 2024-09-18